Hopes for Novel Stroke Drug Dashed in Trial

]]>(MedPage Today) -- LOS ANGELES--A putative neuroprotective agent failed to improve stroke patients' outcomes when given in conjunction with endovascular thrombectomy in the ESCAPE-NA1 trial, although those not given a thrombolytic did appear...